Laparoscopic surgery in urological oncology: brief overview
Jose R Colombo1, Georges P Haber, Mauricio Rubinstein
1Section of Laparoscopic and Robotic Surgery, Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Summary
Laparoscopic surgery in urological oncology shows promising intermediate-term results comparable to open procedures. This review covers outcomes for adrenal, kidney, bladder, prostate, and testicular cancers, addressing complications and recurrence.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Laparoscopic surgery is increasingly adopted in urological oncology.
- High-volume centers offer valuable insights into its application.
- Evidence for its oncological safety and efficacy is crucial.
Purpose of the Study:
- To review the experience of a high-volume center with laparoscopic surgery in urological oncology.
- To analyze oncological outcomes for various malignancies treated laparoscopically.
- To address specific concerns such as complications and port-site recurrence.
Main Methods:
- Retrospective review of a high-volume center's laparoscopic urological oncology cases.
- Comprehensive literature review of relevant published series.
- Analysis of oncological outcomes, complications, and recurrence patterns.
Main Results:
- Laparoscopic approaches were applied to adrenal, kidney, upper tract transitional cell carcinoma, bladder, prostate, and testicular malignancies.
- Intermediate-term oncological data appears encouraging.
- Outcomes are comparable to traditional open surgery.
Conclusions:
- Laparoscopic surgery is a viable and effective option in urological oncology.
- Intermediate-term oncological control is comparable to open surgery.
- Careful consideration of complications and recurrence is necessary.